- Quince Therapeutics Inc Annual Shareholders Meeting TranscriptMay 24, 2023
- Cortexyme Inc To Discuss The GAIN Trial Top-Line Results Call TranscriptOct 26, 2021
- Cortexyme Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2021
- Cortexyme Inc at Canaccord Genuity Growth Conference (Virtual) TranscriptAug 11, 2021
- Cortexyme Inc Corporate To Discuss Innovation in Alzheimers Disease -- Getting to the Root Cause of Neurodegeneration Webinar TranscriptJul 30, 2021
- Cortexyme Inc Corporate To Discuss Innovation in Periodontal Disease -- A Major Unmet Medical Need Webinar TranscriptJul 23, 2021
- Cortexyme Inc at JMP Securities Life Sciences Virtual Conference TranscriptJun 16, 2021
- Cortexyme Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2021
- Cortexyme Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Cortexyme Inc at Stifel CNS Day - Fireside Chat TranscriptApr 01, 2021
- Cortexyme Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 16, 2021
- Cortexyme Inc GAIN Trial Interim Analysis Update Call TranscriptDec 04, 2020
Cortexyme Inc at JMP Securities Life Sciences Virtual Conference Transcript
Great. Well, thank you again for joining us this afternoon at the JMP Securities Life Science Conference. Excited to have Cortexyme join us next and the company's CEO, Casey Lynch. Casey, welcome, really appreciate you being here.
Obviously, a really exciting year for Cortexyme with the Phase III -- Phase II/III GAIN study. It's still on track to read out in 4Q. Also, obviously, as Tom talked about in the Alzheimer's world and how that recent FDA decision could impact you, you guys and everybody else, and would love to get your thoughts there. But maybe let's just start off with a high-level overview. If you could just give us a quick 30-second overview of Cortexyme and the work you're doing in the Alzheimer's space.
Yes, absolutely. We have a new approach to Alzheimer's, which we believe is upstream of not only the amyloid plaques and the tau
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)